Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m6A-dependent manner
Feifei Che, Xuemei Ye, Yu Wang, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 5, pp. 2033-2050
Closed Access | Times Cited: 20

Showing 20 citing articles:

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 59
Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4
Cong-Jie Chen, Jieyun Huang, Jianqing Huang, et al.
Cell Cycle (2023) Vol. 22, Iss. 8, pp. 986-1004
Open Access | Times Cited: 21
New insights into the regulation of METTL3 and its role in tumors
Jin Qiu, Huinan Qu, Chengshi Quan
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6
Yachun Jia, Yu Xiao, Rui Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 16
KIAA1429 increases FOXM1 expression through YTHDF1–mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma
Yue Wu, Y. Luo, Xingchen Yao, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 5
Enhancing staging in multiple myeloma using an m6A regulatory gene-pairing model
Yating Deng, Hongkai Zhu, Hongling Peng
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
YY1-induced transcription of AKR1C3 activates the Hedgehog signalling pathway to enhance lenalidomide resistance and glycolytic activity in multiple myeloma cells
Chen Yang, Aijia Zhang, Yuan Wang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184/CARM1 axis in multiple myeloma
Gang Wang, Wenping Wu, Donghua He, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Research progress on N6-methyladenosine and non-coding RNA in multiple myeloma
Xiaoqi Sun, Yongming Zhou, Wenwei Zhu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2
Xiaoqing Huang, Zhiyong Yang, Yanwen Li, et al.
Annals of Hematology (2023) Vol. 102, Iss. 7, pp. 1801-1810
Closed Access | Times Cited: 10
Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing
Zhengxu Sun, Jiamei Ji, Yating Li, et al.
Blood Advances (2023) Vol. 7, Iss. 15, pp. 4148-4159
Open Access | Times Cited: 10
Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus
P. J. Jayasree, Shalmoli Dutta, Pragati Karemore, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3042-3058
Closed Access | Times Cited: 10
N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1
Jing Bao, Tingting Xu, Wanjie Wang, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 11, pp. 3077-3089
Closed Access | Times Cited: 3
Novel Insights into the Links between N6-Methyladenosine and Regulated Cell Death in Musculoskeletal Diseases
Juanjuan Han, C Wang, Haolin Yang, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 514-514
Open Access | Times Cited: 3
YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B
Shijiang Wang, Jiangbo Nie, Kaiying Xu, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9590-9613
Open Access | Times Cited: 7
METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of β-catenin/NANOG
Chunlei Sun, Jiong Chen, Zhiwei Xing, et al.
Journal of Cancer (2023) Vol. 14, Iss. 8, pp. 1407-1416
Open Access | Times Cited: 6
MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance
Weiguo Lu, Hui Huang, Zhanjie Xu, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0311419-e0311419
Open Access | Times Cited: 1
The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
Patrick Nylund, Berta Garrido-Zabala, Antonia Kalushkova, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis
Hengyou Weng, Huilin Huang, Jianjun Chen
Advances in experimental medicine and biology (2023), pp. 105-123
Closed Access | Times Cited: 2
m1A regulator‑mediated methylation modifications and gene signatures and their prognostic value in multiple myeloma
Jiaqi Fu, Xingjun Han, Wei Gao, et al.
Experimental and Therapeutic Medicine (2024) Vol. 29, Iss. 1
Open Access
Page 1

Scroll to top